CENTESSA PHARMACEUTICALS earnings per share and revenue

260 earnings per share for the last quarter are -0.81 EUR whereas the estimation was -0.41 EUR which accounts for -98.82% surprise. Company revenue for the same period amounts to 0.00 EUR despite the estimated figure of 0.00 EUR. Estimated earnings per share for the next quarter are -0.31 EUR, and revenue is expected to reach 0.00 EUR. Also watch annual changes over time to get a bigger picture of 260 earnings per share and revenue dynamics.